CD4 and myeloid sarcoma: This supports the hypothesis in MS that CNS autoimmunity is either initiated or maintained by pathogenic CD4+ T cell responses which are initially primed by exogenous antigens but can respond to autoantigens, leading to their recruitment to the brain where they mediate inflammatory tissue damage.